Amgen Loses Patent Fight Against Coherus Over Neulasta Copy (1) – Bloomberg Law

Amgen Loses Patent Fight Against Coherus Over Neulasta Copy (1)  Bloomberg Law

Amgen lost its appeal in an infringement lawsuit the company filed against Coherus BioSciences over its Neulasta product.